Results from a narrative review published in the Journal of Medical Ethics suggest broad yet conditional support for data sharing among patients and the general public, with many studies citing concerns about confidentiality, privacy, data security, risk management, and accountability.
Medical school application costs may prevent students from lower-income backgrounds from entering the profession of medicine.
The relatively recent submissions by state policymakers requesting to close their Medicaid formularies highlighted ethical concerns regarding access and treatment of patients who are poor or vulnerable.
The growth of drug spending in the United States associated with government-protected market exclusivity is likely to continue.
Based on initial gains in health care access from the passage of the 2010 Patient Protection and ACA, the ACP offers recommendations on how to improve the law and achieve universal health care coverage.
FDA Commissioner, Scott Gottlieb MD, said, “The FDA shares the goal of ensuring that American patients have access to quality and affordable care that meets their needs.”
April 28, 2018 is National Prescription Drug Take Back Day.
Katie Burk, MPH, presented measures undertaken by the city of San Francisco to provide integrated responses to the concurrent HIV/HCV and opioid public health epidemics.
The agency took this action after Triangle Pharmanaturals LLC failed to cooperate with the FDA’s request to conduct a voluntary recall.
Lawyers make things complicated — including policies requiring mandatory influenza vaccinations for healthcare workers.
